RSL Care RDNS Limited made an offer by way of a Scheme of Arrangement to acquire Japara Healthcare Limited (ASX:JHC) for approximately AUD 320 million on June 15, 2021. The indicative cash price offered under the Bolton Clarke Indicative Proposal is AUD 1.22 per share. This price would be adjusted downwards for any dividend declared prior to implementing a scheme. The Bolton Clarke Indicative Proposal notes that entry into legally binding obligations to implement the proposed scheme is subject to Completion of due diligence to Bolton Clarke’s satisfaction; Binding financing arrangements with third parties, A unanimous recommendation from all Japara Directors to vote in favour of the transaction and Execution of final, agreed transaction documentation. The Japara Board has considered the Bolton Clarke Indicative Proposal and obtained advice from its financial and legal advisors. The Board has determined that it is appropriate to offer Bolton Clarke due diligence access so that Bolton Clarke can develop a binding proposal. This is consistent with the due diligence access provided to Little Company of Mary Health Care Ltd. Shareholders do not need to take any action in relation to the Bolton Clarke Indicative Proposal and are cautioned there is no certainty that the Bolton Clarke Indicative Proposal will result in a transaction. The Board of Japara is being advised by Macquarie Capital and Herbert Smith Freehills.